Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03534544Completed
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System
Diabetes Mellitus, Type 1
PrincipalinvestigatorStart date: 2018-08-23
NCT02925299Not ApplicableCompleted
Day and Night Closed-loop in Young People With Type 1 Diabetes
Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more
PrincipalinvestigatorStart date: 2017-05-12
NCT00831389Not ApplicableCompleted
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
Type 1 Diabetes Mellitus
Principalinvestigator

Research Network

Collaboration Network

40 collaborators·63 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Linda DiMeglio, MD

Indiana University

Similar
3 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Autoimmune DiseasesDiabetes Mellitus+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Nelly Mauras, MD

Nemours Children's Health System

Similar
2 trials

Shared therapeutic areas:

Diabetes MellitusDiabetes Mellitus, Type 1Autoimmune Diseases+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Paul Wadwa, MD

University of Colorado, Denver

Similar
2 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Autoimmune DiseasesDiabetes Mellitus+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Louise Denvir, MD

Nottingham Children's Hospital

Similar
1 trials

Shared therapeutic areas:

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Roman Hovorka, PhD

University of Cambridge

Similar
13 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes MellitusEndocrine System Diseases+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Bruce Buckingham, MD

Stanford University

Similar
24 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes MellitusAutoimmune Diseases+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+8 more
Collaborated on 1 trial
Similarity Score54%

Fiona Campbell, MD

The Leeds Teaching Hospitals NHS Trust

Similar
1 trials

Shared therapeutic areas:

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Nikki C Davis, MD

Southampton Children's Hospital

Similar
1 trials

Shared therapeutic areas:

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Rachel Besser, MD

Oxford Children's Hospital

Similar
1 trials

Shared therapeutic areas:

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Ajay Thankamony, MD

University of Cambridge

Similar
1 trials

Shared therapeutic areas:

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustIndiana University+7 more
Collaborated on 1 trial
Similarity Score54%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03534544PrincipalInvestigator

Patient and Parent Preferences for an On-Body Automated Insulin Delivery System

Diabetes Mellitus, Type 1
Completed
NCT02925299Not ApplicablePrincipalInvestigator

Day and Night Closed-loop in Young People With Type 1 Diabetes

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1+2 more
Completed
NCT00831389Not ApplicablePrincipalInvestigator

Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia

Type 1 Diabetes Mellitus
Completed
NCT01787318Early Phase 1PrincipalInvestigator

Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes

Type 1 Diabetes
Completed

All 4 trials loaded